Setmelanotide Phase 2 Interim Data Due for Prader-Willi Syndrome
The MC4R-pathway agonist is under scrutiny as a potential model for appetite-regulating therapeutics at the rare-diseas…
The MC4R-pathway agonist is under scrutiny as a potential model for appetite-regulating therapeutics at the rare-diseas…
Editorial note: submission reviewed and declined. No ingredient, mechanism, clinical endpoint, or regulatory hook appli…
As clean-label beauty-from-outside converges with nutricosmetics, topical actives targeting neck laxity signal a formul…
The Sharpsburg opening signals continued franchisee demand for specialty dessert concepts as operators seek differentia…
As better-burger operators eye experiential retail, the Calgary Stampede debut tests consumer appetite for premium QSR …
As GLP-1 adoption accelerates, new CE data highlights the pharmacist's expanding role in bridging gaps between clinical…
Occasion-based LTO strategy reflects broader foodservice trend of sports-event tie-ins driving traffic and beverage att…
The promotion layers gamification onto foodservice purchasing, a tactic gaining traction as operators compete for share…
Editorial note: This release covers tertiary-care AI and precision medicine — outside Functional News coverage scope.
Functional News covers ingredients, formulations, clinical nutrition, and supplement regulation — this submission falls…
Submitted content covers hospital AI and precision medicine infrastructure — outside the functional foods and nutraceut…
The Utah-based brand has expanded from a single deer antler spray SKU to a full portfolio spanning pre-workouts, creati…